Literature DB >> 7919381

Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26).

K Suzukawa1, E Parganas, A Gajjar, T Abe, S Takahashi, K Tani, S Asano, H Asou, N Kamada, J Yokota.   

Abstract

Structural alterations occur in the long arm of chromosome 3 in approximately 2% of patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). The major alterations are inv(3)(q21q26) and t(3:3)(q21;q26) and are often classified as the 3q21q26 syndrome. We previously reported that the EVI1 gene is transcriptionally activated in AMLs with t(3;3)(q21;q26) and inv(3)(q21q26) and that the chromosomal breakpoints at 3q26 in the translocations were 5' of the EVI1 gene, whereas the breakpoints in the inversion cases were 3' of the gene. In these studies, four additional cases of AML with inv(3)(q21q26) are shown to express the EVI1 gene and to have breakpoints 3' of the gene. To characterize the 3q21 breakpoint region, cosmid and phage clones were isolated that cover approximately 100 kb. At 3q21, the breakpoints for both AMLs with t(3;3)(q21;q26) and inv(3)(q21q26) were found to cluster over a region of approximately 50 kb downstream of the Ribophorin I gene. The results indicate a common mechanism for the translocations and inversions and support the hypothesis that the transcriptional activation of the EVI1 gene is mediated by enhancer elements associated with the Ribophorin I gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919381

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence.

Authors:  Martina Konantz; Elisa Alghisi; Joëlle S Müller; Anna Lenard; Virginie Esain; Kelli J Carroll; Lothar Kanz; Trista E North; Claudia Lengerke
Journal:  EMBO J       Date:  2016-09-16       Impact factor: 11.598

2.  THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer.

Authors:  Federica Panebianco; Lindsey M Kelly; Pengyuan Liu; Shan Zhong; Sanja Dacic; Xiaosong Wang; Aatur D Singhi; Rajiv Dhir; Simion I Chiosea; Shih-Fan Kuan; Rohit Bhargava; David Dabbs; Sumita Trivedi; Manoj Gandhi; Rachel Diaz; Abigail I Wald; Sally E Carty; Robert L Ferris; Adrian V Lee; Marina N Nikiforova; Yuri E Nikiforov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

3.  Can a high platelet count be responsible for diabetes insipidus in acute myelogenous leukemia with monosomy 7 and inversion 3 (q21q26)?

Authors:  Mehmet Sonmez; Nergiz Erkut; T Songul Tat; Figen Celep; Umit Cobanoglu; H Onder Ersoz
Journal:  Int J Hematol       Date:  2009-08-12       Impact factor: 2.490

4.  Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.

Authors:  Kathryn E Boyd; Ying-Yi Xiao; Kai Fan; Amanda Poholek; Neal G Copeland; Nancy A Jenkins; Archibald S Perkins
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

5.  Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.

Authors:  S Fears; C Mathieu; N Zeleznik-Le; S Huang; J D Rowley; G Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

6.  Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q.

Authors:  M K Wirtz; J R Samples; P L Kramer; K Rust; J R Topinka; J Yount; R D Koler; T S Acott
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 7.  Molecular pathogenesis of MDS.

Authors:  Hisamaru Hirai
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

8.  Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.

Authors:  Yang Du; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

Review 9.  Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Authors:  Stephanie Beurlet; Christine Chomienne; Rose Ann Padua
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 10.  Leukemogenesis of the EVI1/MEL1 gene family.

Authors:  Kazuhiro Morishita
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.